A new breed of home appliance will help help save the lives of Australians who have a heart attack, stroke or other condition that can lead to a respiratory failure.
A new generation is expected to be available for use within two years, after the introduction of the AERAS product line.
The AERAs is designed to treat the most common heart attacks and strokes with an array of products, which includes a cardiac monitor, an ECG, a heart rate monitor, blood pressure and electrocardiogram (ECG) device, as well as respiratory monitoring and diagnostic equipment.
At the heart of the new product is a heart-shaped battery, which has the capacity to provide the devices for up to 10 hours per charge.
This is enough power to power a battery pack that can be connected to an external monitor, the Aeras device, an electric power adaptor, an electronic monitoring device or even an electric motor.
One of the key features of the product is the addition of an oxygen mask, which is designed specifically to deliver oxygen to the heart, so the heart is kept stable during the course of the event.
It is believed the oxygen mask will be the first in the world to be used in this way.
Aeras was designed by scientists at the University of Melbourne and the University to help manage the symptoms of severe and life-threatening heart failure.
Professor Stephen R. McEwan, the director of the university’s cardiovascular and cardiac research program, said the technology was “revolutionary” and would revolutionise the way patients are treated in the event of a heart failure diagnosis.
“The fact that the devices can be adapted to a variety of health conditions and have a wide range of uses shows how the Australian healthcare system has been working on this for a very long time,” he said.
He said the Aercas was “unique” because it would not require a physical examination or medical records to be filled out.
“[The device] is very simple to use and it will be very easy for anyone to use.”
The Aercases battery has a power capacity of 300 watts, which works out to about 20 times the power that an average battery pack provides.
But Professor McEwin said that this was a significant increase over the capacity of a typical home battery, of about 150 watts.
While a typical battery is about 30 per cent full when it is full, the range of Aercase batteries could potentially supply up to three times that amount.
“The technology will enable us to deliver a device that’s as simple as it is effective,” he added.
Currently, it can be found in some hospitals and private homes, but Professor McSweeney said that was only the beginning.
In the future, he said Aercasin could be used on the outside of the body as well.
“There are some very interesting uses in the medical field,” he explained.
For example, the batteries could be inserted into the lungs to provide oxygen to people who have difficulty breathing in their own bodies.
Dr McEwen said the Australian government had already made progress in the field of cardiac monitoring and was investing $2 million a year to support innovation.
Australia currently has around 4,000 people on the waiting list for life-saving heart surgeries, with the most recent figures showing that around 50 per cent of Australians had lost a loved one.
When the AERCAS is ready for use, it will not only help to save lives, it could also help Australians understand how their health is progressing.
What are the key health benefits of a AERASE device?
AERASE technology is designed for patients who have suffered from a heart condition such as a heart valve condition, a congenital heart disease, congestive heart failure, coronary artery disease or stroke.
Its primary function is to help to detect any changes in blood flow in the heart.
These can include the presence of an abnormal heartbeat, the sudden change in the rhythm of the heart’s beating or any abnormal breathing patterns.
Patients with a heart defect may experience a sudden increase in blood pressure or a decrease in oxygen in their lungs, which may cause a rapid decline in their heart’s function.
As the heart stops beating, oxygen levels in the blood drop and the body loses the ability to keep the blood pumping.
During a heart transplant operation, the heart muscle is removed, allowing the body to take over the functions of the brain.
Some patients may also have problems with blood flow and may also experience changes to their skin, as they lose the ability of breathing.
Once the heart has been removed, it is replaced by a blood vessel, which allows for better blood flow to the muscles and nerves that control the body.
There is also a possibility that a heart infection could lead to complications, which could lead the patient to need hospitalisation and surgery.
If the patient